권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Sever PS, (2003) Prevention of coronaryand stroke events with atorvastatin in hypertensive patients whohave average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid LoweringArm(ASCOT-LLA): a multicentre randomised controlledtrial, | 미소장 |
| 2 | The Scandinavian Simvastatin Survival Study, (1994) Randomised trialof cholesterol lowering in 4444 patients with coronary heartdisease, | 미소장 |
| 3 | Shepherd J, (1995) Prevention of coronaryheart disease with pravastatin in men with hypercholesterolemia.West of Scotland Coronary Prevention Study Group, | 미소장 |
| 4 | Jun JE, (2001) Cholesterol lowering therapy in coronary artery disease, | 미소장 |
| 5 | Isley WL, (2001) Pitavastatin(NK-104), a new HMG-CoA reductaseinhibitor, | 미소장 |
| 6 | Park S, (2005) A randomized,open-label studyto evaluate the efficacy and safety of pitavastatin comparedwith simvastatin in Korean patients with hypercholesterolemia, | 미소장 |
| 7 | Expert Panel on Detection, Evaluation, and Treatment of HighBlood Cholesterol In Adults, (2001) Executive Summary of The ThirdReport of The National Cholesterol Education Program(NCEP)Expert Panel on Detection, Evaluation, And Treatment of HighBlood Cholesterol In Adults(Adult Treatment Panel III), | 미소장 |
| 8 | Cannon CP, (2004) Intensive versusmoderate lipid lowering with statins after acute coronary syndromes, | 미소장 |
| 9 | Bae JH, (2001) Multicenter clinical trial of atorvastatin in patients withhypercholesterolemia, | 미소장 |
| 10 | LaRosa JC, (2005) Intensive lipid loweringwith atorvastatin in patients with stable coronary disease, | 미소장 |
| 11 | Grundy SM, (2004) Implications of recentclinical trials for the National Cholesterol Education ProgramAdult Treatment Panel III guidelines, | 미소장 |
| 12 | Cannon CP, (2006) Meta-analysis of cardiovascular outcomes trials comparing intensiveversus moderate statin therapy, | 미소장 |
| 13 | Nissen SE, (2006) Effect of very high-intensitystatin therapy on regression of coronary atherosclerosis, | 미소장 |
| 14 | Nissen SE, (2004) Effect of intensivecompared with moderate lipid-lowering therapy on progressionof coronary atherosclerosis:a randomized controlled trial, | 미소장 |
| 15 | Alsheikh-Ali AA, (2005) The safetyof rosuvastatin as used in common clinical practice:a postmarketinganalysis, | 미소장 |
| 16 | Grundy SM, (2005) The issue of statin safety: where do we stand?, | 미소장 |
| 17 | Blasetto JW, (2003) Efficacyof rosuvastatin compared with other statins at selected startingdoses in hypercholesterolemic patients and in special populationgroups, | 미소장 |
| 18 | Kawano H, (2006) Pravastatin decreases blood pressure in hypertensiveand hypercholesterolemic patients receiving antihypertensivetreatment, | 미소장 |
| 19 | Pelat M, (2003) Rosuvastatin decreases caveolin-1 and improves nitric oxidedependentheart rate and blood pressure variability in apolipoproteinE-/- mice in vivo, | 미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: 정기간행물실(524호) / 서가번호: 국내17
2021년 이전 정기간행물은 온라인 신청(원문 구축 자료는 원문 이용)
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.